$ACA Cashflow Statement | Understand Stock

$ACA

$149.16 +$0.13 (0.09%) Live

$ACA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating activities:
Net income
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, depletion, and amortization
Impairment charge
Stock-based compensation expense
Gain on disposition of assets and sale of businesses
Provision for deferred income taxes
Gain on disposition of property, plant, equipment, and other assets
(Gain) loss on sale of businesses
(Increase) decrease in other assets
Increase (decrease) in other liabilities
Other
Changes in current assets and liabilities:
(Increase) decrease in receivables
(Increase) decrease in inventories
(Increase) decrease in other current assets
Increase (decrease) in accounts payable
Increase (decrease) in advance billings
Increase (decrease) in accrued liabilities
Net cash provided by operating activities
Investing activities:
Proceeds from disposition of assets
Proceeds from sale of businesses
Capital expenditures
Cash received (paid) for acquisitions
Net cash required by investing activities
Financing activities:
Payments to retire debt
Proceeds from issuance of debt
Shares repurchased
Dividends paid to common shareholders
Purchase of shares to satisfy employee tax on vested stock
Holdback payment from acquisition
Debt issuance costs
Other
Net cash (required) provided by financing activities

Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period

Comments